UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 4, 2014
The Spectranetics Corporation
(Exact name of registrant as specified in its charter)
|
| | | | | | |
| | Delaware | | 000-19711 | | 84-0997049 | |
| | (State or other jurisdiction | | (Commission | | (IRS Employer | |
| | of incorporation) | | File Number) | | Identification No.) | |
|
|
| 9965 Federal Drive |
| Colorado Springs, Colorado 80921 |
| (Address of principal executive offices) (Zip Code) |
Registrant’s telephone number, including area code: (719) 633-8333
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure.
On December 4, 2014, The Spectranetics Corporation, a Delaware corporation (“Spectranetics”), is hosting an Analyst & Investor Meeting in New York City to discuss Spectranetics’ current operations, future growth opportunities and 2015 financial outlook. On December 4, 2014, Spectranetics issued a press release describing the highlights of its conference presentation. A copy of the press release is furnished as Exhibit 99.1 of this report.
The information under Item 7.01 and in Exhibit 99.1 of this report is being furnished and shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information under Item 7.01 and in Exhibit 99.1 of this report shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
|
| |
| Exhibit No. | Description |
| | |
| 99.1 | Press release issued by The Spectranetics Corporation on December 4, 2014. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
| | | |
| | | THE SPECTRANETICS CORPORATION |
| | | (registrant) |
| | | |
| | | |
| Date: | December 4, 2014 | By: | /s/ Jeffrey A. Sherman |
| | | | Jeffrey Sherman |
| | | | Vice President, Deputy General Counsel and Corporate Secretary |
| | | | |
EXHIBIT INDEX
|
| |
| Exhibit No. | Description |
| | |
| 99.1 | Press release issued by The Spectranetics Corporation on December 4, 2014. |
